Search

Author/Creator Berg, T.

1. Real‐world use, effectiveness and safety of anti‐viral treatment in chronic hepatitis C genotype 3 infection. Issue 5 (12th January 2017)

Authors:
Cornberg, M.; Petersen, J.; Schober, A.; Mauss, S.; Böker, K. H. W.; Link, R.; Günther, R.; Serfert, Y.; Pfeiffer‐Vornkahl, H.; Manns, M. P.; Sarrazin, C.; Hüppe, D.; Berg, T.; Niederau, C.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 45:Issue 5(2017)
Page Start:
688
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis. Issue 10 (21st September 2017)

Authors:
Stirnimann, G.; Berg, T.; Spahr, L.; Zeuzem, S.; McPherson, S.; Lammert, F.; Storni, F.; Banz, V.; Babatz, J.; Vargas, V.; Geier, A.; Stallmach, A.; Engelmann, C.; Trepte, C.; Capel, J.; De Gottardi, A.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 46:Issue 10(2017)
Page Start:
981
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Hepatitis C viral dynamics during ribavirin priming differ according to prior treatment response and HCV type. Issue 11 (26th June 2016)

Authors:
Fülöp, B.; Mihm, U.; Rohde, P.; Buggisch, P.; Schlosser, B.; Biermer, M.; Brodzinski, A.; Fischer, J.; Böhm, S.; van Bömmel, F.; Sarrazin, C.; Berg, T.
Journal:
Journal of viral hepatitis
Issue:
Volume 23:Issue 11(2016)
Page Start:
866
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B. Issue 5 (2nd July 2018)

Authors:
El Sharkawy, R.; Thabet, K.; Lampertico, P.; Petta, S.; Mangia, A.; Berg, T.; Metwally, M.; Bayoumi, A.; Boonstra, A.; Brouwer, W. P.; Smedile, A.; Abate, M. L.; Loglio, A.; Douglas, M. W.; Khan, A.; Santoro, R.; Fischer, J.; Leeming, D. J.; Liddle, C.; George, J.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 48:Issue 5(2018)
Page Start:
564
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Functional connectivity alterations in patients with chronic hepatitis C virus infection: A multimodal MRI study. Issue 3 (4th November 2016)

Authors:
Kharabian Masouleh, S.; Herzig, S.; Klose, L.; Roggenhofer, E.; Tenckhoff, H.; Kaiser, T.; Thöne‐Otto, A.; Wiese, M.; Berg, T.; Schroeter, M. L.; Margulies, D. S.; Villringer, A.
Journal:
Journal of viral hepatitis
Issue:
Volume 24:Issue 3(2017)
Page Start:
216
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Historical epidemiology of hepatitis C virus (HCV) in selected countries. (May 2014)

Authors:
Bruggmann, P.; Berg, T.; Øvrehus, A. L. H.; Moreno, C.; Brandão Mello, C. E.; Roudot‐Thoraval, F.; Marinho, R. T.; Sherman, M.; Ryder, S. D.; Sperl, J.; Akarca, U.; Balık, İ.; Bihl, F.; Bilodeau, M.; Blasco, A. J.; Buti, M.; Calinas, F.; Calleja, J. L.; Cheinquer, H.; Christensen, P. B.
Journal:
Journal of viral hepatitis
Issue:
Volume 21(2014)Supplement 1
Page Start:
5
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. (May 2014)

Authors:
Razavi, H.; Waked, I.; Sarrazin, C.; Myers, R. P.; Idilman, R.; Calinas, F.; Vogel, W.; Mendes Correa, M. C.; Hézode, C.; Lázaro, P.; Akarca, U.; Aleman, S.; Balık, İ.; Berg, T.; Bihl, F.; Bilodeau, M.; Blasco, A. J.; Brandão Mello, C. E.; Bruggmann, P.; Buti, M.
Journal:
Journal of viral hepatitis
Issue:
Volume 21(2014)Supplement 1
Page Start:
34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗